Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 344, Issue 2, 2013, Pages 329-338

  Czoty, Paul W ^a   Nader, Michael A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; COCAINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ETICLOPRIDE; PROPYLNORAPOMORPHINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG TARGETING; EXPERIMENTAL MONKEY; FEEDING BEHAVIOR; LIGAND BINDING; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; REPEATED DRUG DOSE; SOCIAL STATUS;

ANIMALS; CHOICE BEHAVIOR; COCAINE; COCAINE-RELATED DISORDERS; DOMINANCE-SUBORDINATION; DOPAMINE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG PARTIAL AGONISM; FEEDING BEHAVIOR; LIGANDS; MACACA FASCICULARIS; MALE; PIPERAZINES; QUINOLONES; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 84872725215     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.201012     Document Type: Article

References (55)

1. Barrett JE and Katz JL (1981) Drug effects on behaviors maintained by different events, in Advances in Behavioral Pharmacology, Vol. 3 (Thompson T, Dews PB, and McKim WA, eds, ed) pp 119-168, Academic Press, New York, NY.
2. Bergman J (2008) Medications for stimulant abuse: agonist-based strategies and preclinical evaluation of the mixed-action D-sub-2 partial agonist aripiprazole (Abilify). Exp Clin Psychopharmacol 16:475-483.
3. Bergman J, Kamien JB, and Spealman RD (1990) Antagonism of cocaine selfadministration by selective dopamine D(1) and D(2) antagonists. Behav Pharmacol 1:355-363.
4. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155. (Pubitemid 19261957)
5. Bradberry CW (2000) Acute and chronic dopamine dynamics in a nonhuman primate model of recreational cocaine use. J Neurosci 20:7109-7115.
6. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca FD, and Molinoff PB (2002) Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 302:381-389. (Pubitemid 34680462)
7. Carroll FI, Howell LL, and Kuhar MJ (1999) Pharmacotherapies for treatment of cocaine abuse: preclinical aspects. J Med Chem 42:2721-2736. (Pubitemid 29370417)
8. Childress AR and O'Brien CP (2000) Dopamine receptor partial agonists could address the duality of cocaine craving. Trends Pharmacol Sci 21:6-9. (Pubitemid 30102182)
9. Chiodo KA, Läck CM, and Roberts DC (2008) Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats. Psychopharmacology (Berl) 200:465-473.
10. Czoty PW, Gage HD, and Nader MA (2010) Differences in D2 dopamine receptor availability and reaction to novelty in socially housed male monkeys during abstinence from cocaine. Psychopharmacology (Berl) 208:585-592.
11. Czoty PW, Gould RW, Martelle JL, and Nader MA (2011) Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology 36:539-547.
12. Czoty PW, Gould RW, and Nader MA (2009) Relationship between social rank and cortisol and testosterone concentrations in male cynomolgus monkeys (Macaca fascicularis). J Neuroendocrinol 21:68-76.
13. Czoty PW, McCabe C, and Nader MA (2005) Assessment of the relative reinforcing strength of cocaine in socially housed monkeys using a choice procedure. J Pharmacol Exp Ther 312:96-102. (Pubitemid 40096457)
14. Czoty PW and Nader MA (2012) Individual differences in the effects of environmental stimuli on cocaine choice in socially housed male cynomolgus monkeys. Psychopharmacology (Berl) 224:69-79.
15. Feltenstein MW, Do PH, and See RE (2009) Repeated aripiprazole administration attenuates cocaine seeking in a rat model of relapse. Psychopharmacology (Berl) 207:401-411.
16. Gay EA, Urban JD, Nichols DE, Oxford GS, and Mailman RB (2004) Functional selectivity of D2 receptor ligands in a Chinese hamster ovary hD2L cell line: evidence for induction of ligand-specific receptor states. Mol Pharmacol 66:97-105. (Pubitemid 38822091)
17. Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, and Moeller FG (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21:522-526. (Pubitemid 32937435)
18. Grabowski J, Rhoades H, Silverman P, Schmitz JM, Stotts A, Creson D, and Bailey R (2000) Risperidone for the treatment of cocaine dependence: randomized, doubleblind trial. J Clin Psychopharmacol 20:305-310. (Pubitemid 30318358)
19. Haney M, Rubin E, and Foltin RW (2011) Aripiprazole maintenance increases smoked cocaine self-administration in humans. Psychopharmacology (Berl) 216:379-387.
20. Haney M, Ward AS, Foltin RW, and Fischman MW (2001) Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) 155:330-337. (Pubitemid 32523103)
21. Hollister LE (1992) Neuroleptic dysphoria: so what's new? Biol Psychiatry 31: 531-532.
22. Kaplan JR, Manuck SB, Clarkson TB, Lusso FM, and Taub DM (1982) Social status, environment, and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 2: 359-3678.
23. Katz JL (1990) Models of relative reinforcing efficacy of drugs and their predictive utility. Behav Pharmacol 1:283-301.
24. Kimmel HL, Nye JA, Voll R, Mun J, Stehouwer J, Goodman MM, Votaw JR, Carroll FI, and Howell LL (2012) Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeys. Synapse 66:501-5078.
25. Koffarnus MN, Collins GT, Rice KC, Chen J, Woods JH, and Winger G (2012) Selfadministration of agonists selective for dopamine D2, D3, and D4 receptors by rhesus monkeys. Behav Pharmacol 23:331-3378.
26. Lile JA, Stoops WW, Glaser PE, Hays LR, and Rush CR (2011) Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans. J Psychopharmacol 25:1469-1479.
27. Lile JA, Stoops WW, Hays LR, and Rush CR (2008) The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance II: increased aripipirazole dose and maintenance period. Am J Drug Alcohol Abuse 34:721-729 e.
28. McGavin JK and Goa KL (2002) Aripiprazole. CNS Drugs 16:779-786, discussion 787-7878. (Pubitemid 35252727)
29. Mallikaarjun S, Salazar DE, and Bramer SL (2004) Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers. J Clin Pharmacol 44:179-187. (Pubitemid 38114317)
30. Meini M, Moncini M, Cecconi D, Cellesi V, Biasci L, Simoni G, Ameglio M, Pellegrini M, Forgione RN, and Rucci P (2011) Safety, tolerability, and self-rated effects of aripiprazole and ropinirole treatment for cocaine dependence: a pilot study. Am J Addict 20:179-180.
31. Miczek KA and Gold LH (1983) d-Amphetamine in squirrel monkeys of different social status: effects on social and agonistic behavior, locomotion, and stereotypies. Psychopharmacology (Berl) 81:183-190. (Pubitemid 14249642)
32. Morgan D, Grant KA, Gage HD, Mach RH, Kaplan JR, Prioleau O, Nader SH, Buchheimer N, Ehrenkaufer RL, and Nader MA (2002) Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci 5: 169-174. (Pubitemid 34121585)
33. Morgan D, Grant KA, Prioleau OA, Nader SH, Kaplan JR, and Nader MA (2000) Predictors of social status in cynomolgus monkeys (Macaca fascicularis) after group formation. Am J Primatol 52:115-131.
34. Nader MA, Green KL, Luedtke RR, and Mach RH (1999) The effects of benzamide analogues on cocaine self-administration in rhesus monkeys. Psychopharmacology (Berl) 147:143-152. (Pubitemid 30010561)
35. Nader MA, Nader SH, Czoty PW, Riddick NV, Gage HD, Gould RW, Blaylock BL, Kaplan JR, Garg PK, and Davies HM, et al. (2012) Social dominance in female monkeys: dopamine receptor function and cocaine reinforcement. Biol Psychiatry 72:414-421.
36. Negus SS (2003) Rapid assessment of choice between cocaine and food in rhesus monkeys: effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology 28:919-931.
37. Negus SS and Mello NK (2003) Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology (Berl) 167:324-332. (Pubitemid 36712980)
38. Newcomer JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19 (Suppl 1):1-93. (Pubitemid 40677047)
39. Newman AH, Grundt P, and Nader MA (2005) Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutics. J Med Chem 48: 3663-3679. (Pubitemid 40776839)
40. Platt DM, Rowlett JK, and Spealman RD (2002) Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development. Psychopharmacology (Berl) 163:265-282.
41. Pulvirenti L and Koob GF (2002) Being partial to psychostimulant addiction therapy. Trends Pharmacol Sci 23:151-153. (Pubitemid 34270586)
42. Ranaldi R, Wang Z, and Woolverton WL (2001) Reinforcing effects of D2 dopamine receptor agonists and partial agonists in rhesus monkeys. Drug Alcohol Depend 64: 209-217. (Pubitemid 32816964)
43. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237: 1219-1223. (Pubitemid 17131228)
44. Semba J, Watanabe A, Kito S, and Toru M (1995) Behavioural and neurochemical effects of OPC-14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain. Neuropharmacology 34:785-791.
45. Shimokawa Y, Akiyama H, Kashiyama E, Koga T, and Miyamoto G (2005) High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 821:8-14. (Pubitemid 40779580)
46. Sørensen G, Sager TN, Petersen JH, Brennum LT, Thøgersen P, Hee Bengtsen C, Thomsen M, Wörtwein G, Fink-Jensen A, and Woldbye DP (2008) Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology (Berl) 199:37-46.
47. Stoops WW, Lile JA, Lofwall MR, and Rush CR (2007) The safety, tolerability, and subject-rated effects of acute intranasal cocaine administration during aripiprazole maintenance. Am J Drug Alcohol Abuse 33:769-776. (Pubitemid 350125771)
48. Tadori Y, Forbes RA, McQuade RD, and Kikuchi T (2011) In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors. Eur J Pharmacol 668:355-365.
49. Thomsen M, Fink-Jensen A, Woldbye DP, Wörtwein G, Sager TN, Holm R, Pepe LM, and Caine SB (2008) Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology (Berl) 201:43-53.
50. Urban JD, Vargas GA, von Zastrow M, and Mailman RB (2007) Aripiprazole has functionally selective actions at dopamine D2 receptor-mediated signaling pathways. Neuropsychopharmacology 32:67-77. (Pubitemid 44967785)
51. Vocci FJ and Elkashef A (2005) Pharmacotherapy and other treatments for cocaine abuse and dependence. Curr Opin Psychiatry 18:265-270. (Pubitemid 40586109)
52. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Gifford A, Hitzemann R, Ding YS, and Pappas N (1999) Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am J Psychiatry 156:1440-1443. (Pubitemid 29416545)
53. Weed MR and Woolverton WL (1995) The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275:1367-1374. (Pubitemid 26129931)
54. Woolverton WL and Balster RL (1981) Effects of antipsychotic compounds in rhesus monkeys given a choice between cocaine and food. Drug Alcohol Depend 8:69-778.
55. Woolverton WL, Goldberg LI, and Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 230: 678-683. (Pubitemid 14040389)